CLINICAL_TRIALS
trial_result
· 2024-06-10
Clinical Trial Update: A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3) [Phase 3]
Summary
Phase 3 trial results for ruxolitinib cream in pediatric atopic dermatitis have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2024-06-10